Efficacy and safety of low-dose vs medium-dose bevacizumab for radiation-induced brain necrosis in nasopharyngeal carcinoma survivors
{{output}}
Background and purpose: Previous studies had found that bevacizumab could alleviate the brain edema and symptoms in patients with radiation-induced brain necrosis (RN) after radiotherapy for nasopharyngeal carcinoma (NPC). Howeve... ...
